Literature DB >> 17031684

Inflammation of Hoffa's fat pad in the setting of HIV: magnetic resonance imaging findings in six patients.

Hamidreza Torshizy1, Mini N Pathria, Christine B Chung.   

Abstract

OBJECTIVE: To describe MR imaging findings of inflammation of Hoffa's fat pad as a cause of nonspecific knee pain in the HIV-infected population.
DESIGN: Retrospective review. PATIENTS: A retrospective review of 400 consecutive MR imaging studies of the knee performed at two institutions over a six-month period was conducted. Inclusion criteria included HIV infection in conjunction with diffuse high signal intensity throughout Hoffa's fat pad on fluid sensitive sequences. Medical histories and images were reviewed by two musculoskeletal radiologists. Exclusion criteria included post-surgical changes, internal derangement, and/or changes consistent with an active synovial inflammatory process.
RESULTS: Seven HIV-infected subjects with non-specific knee pain were identified, six of whom met imaging inclusion criteria. Findings in Hoffa's fat pad were present in nine MR studies (bilateral in three, and unilateral in three subjects). Other findings include bilateral enlargement of Hoffa's fat pad in one subject, global increase in signal intensity of the suprapatellar fat pad on fluid sensitive sequences in three subjects and of the prefemoral fat pad in four subjects, avascular necrosis in one subject, and a diffuse pattern of patchy bone marrow edema in one subject. Subjects were diagnosed with HIV from 1993-1999, with imaging performed in 2005. Subjects were on HAART medication for an indeterminate, extended duration of time prior to imaging. CD4 levels of subjects ranged from 448-1262 cells/muL (X=727.33 cells/muL).
CONCLUSIONS: While the MR imaging findings of diffuse inflammation of Hoffa's fat pad are nonspecific and unclear in etiology, an association with HIV may exist.

Entities:  

Mesh:

Year:  2006        PMID: 17031684     DOI: 10.1007/s00256-006-0201-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  11 in total

1.  The infrapatellar fat pad: anatomy and clinical correlations.

Authors:  J Gallagher; P Tierney; P Murray; M O'Brien
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-01-28       Impact factor: 4.342

Review 2.  Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis.

Authors:  D Nolan; M John; S Mallal
Journal:  Antivir Ther       Date:  2001-09

3.  Anatomy and clinical significance of the horizontal cleft in the infrapatellar fat pad of the knee: MR imaging.

Authors:  S J Patel; P A Kaplan; R G Dussault; D M Kahler
Journal:  AJR Am J Roentgenol       Date:  1998-06       Impact factor: 3.959

Review 4.  Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.

Authors:  Christine A Wanke; Julian M Falutz; Abby Shevitz; John P Phair; Donald P Kotler
Journal:  Clin Infect Dis       Date:  2001-12-07       Impact factor: 9.079

5.  MR imaging of the infrapatellar fat pad of Hoffa.

Authors:  J A Jacobson; L Lenchik; M K Ruhoy; M E Schweitzer; D Resnick
Journal:  Radiographics       Date:  1997 May-Jun       Impact factor: 5.333

6.  Visceral abdominal-fat accumulation associated with use of indinavir.

Authors:  K D Miller; E Jones; J A Yanovski; R Shankar; I Feuerstein; J Falloon
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

7.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

Review 8.  Musculoskeletal disorders associated with HIV infection and AIDS. Part II: non-infectious musculoskeletal conditions.

Authors:  Jamshid Tehranzadeh; Ramon R Ter-Oganesyan; Lynne S Steinbach
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199

9.  Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.

Authors:  Julia A Johnson; Jeanine B Albu; Ellen S Engelson; Susan K Fried; Yoritaro Inada; Gabriel Ionescu; Donald P Kotler
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-10-07       Impact factor: 4.310

Review 10.  Antiretroviral therapy and the lipodystrophy syndrome.

Authors:  M John; D Nolan; S Mallal
Journal:  Antivir Ther       Date:  2001-03
View more
  6 in total

1.  Pericruciate fat pad of the knee: anatomy and pericruciate fat pad inflammation: cadaveric and clinical study emphasizing MR imaging.

Authors:  Abdalla Youssef Skaf; Guinel Hernandez Filho; Berna Dirim; Mani Wangwinyuvirat; Debra Trudell; Parviz Haghighi; Parvitz Haghigi; Donald Resnick
Journal:  Skeletal Radiol       Date:  2012-06-05       Impact factor: 2.199

2.  Kager's fat pad inflammation associated with HIV infection and AIDS: MRI findings.

Authors:  Alexandre Leme Godoy-Santos; Marcelo Bordalo-Rodrigues; Laercio Rosemberg; Tulio Diniz Fernandes; Ana Lúcia Lei Munhoz Lima; Gilberto Luis Camanho; Nicola Maffulli
Journal:  Skeletal Radiol       Date:  2014-06-12       Impact factor: 2.199

Review 3.  MRI of anterior knee pain.

Authors:  Mohammad Samim; Edward Smitaman; David Lawrence; Hicham Moukaddam
Journal:  Skeletal Radiol       Date:  2014-01-29       Impact factor: 2.199

4.  Hoffa's fat-pad inflammation in an HIV-positive patient.

Authors:  Jonelle Petscavage; Felix S Chew
Journal:  Radiol Case Rep       Date:  2015-11-06

5.  Malignant Fibrohisticytoma of the Knee in a Patient with HIV.

Authors:  Riccardo Gomes Gobbi; Daniel Sequel Rebolledo; Ana Lúcia Munhoz Lima; Alexandre Leme Godoy Dos Santos
Journal:  J Glob Infect Dis       Date:  2012-10

6.  Is treated HIV infection associated with knee cartilage degeneration and structural changes? A longitudinal study using data from the osteoarthritis initiative.

Authors:  Yao Liu; Sarah C Foreman; Gabby B Joseph; Jan Neumann; Phyllis C Tien; Xiaoming Li; Nancy E Lane; Michael C Nevitt; Charles E McCulloch; Thomas M Link
Journal:  BMC Musculoskelet Disord       Date:  2019-05-04       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.